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Abstract 
Water gain in the brain consequent to hyponatremia is counteracted by mechanisms that initially 
include a compensatory displacement of liquid from the interstitial space to cerebrospinal fluid and 
systemic circulation and subsequently an active reduction in cell water accomplished by extrusion 
of intracellular osmolytes to reach osmotic equilibrium. Potassium (K+), chloride (Cl–), amino acids, 
polyalcohols, and methylamines all contribute to volume regulation, with a major contribution of 
ions at the early phase and of organic osmolytes at the late phase of the regulatory process. Experi-
mental models in vitro show that osmolyte fluxes occur via leak pathways for organic osmolytes and 
separate channels for Cl– and K+. Osmotransduction signaling cascades for Cl– and taurine efflux 
pathways involve tyrosine kinases and phosphoinositide kinases, while Ca2+ and serine-threonine 
kinases modulate K+ pathways. In-depth knowledge of the cellular and molecular adaptive mecha-
nisms of brain cells during hyponatremia contributes to a better understanding of the associated 
complications, including the risks of inappropriate correction of the hyponatremic condition. 
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Introduction 
 
The ability to regulate cell volume is an ancient conserved trait present in essentially all 
species throughout evolution. Maintenance of constant cell volume is a homeostatic im-
perative in animal cells. Changes in cell water content by affecting the concentration of 
messenger molecules impair the complex signaling network crucial for cell functioning 
and intercellular communication. Although under physiologic conditions extracellular flu-
ids have a highly controlled osmolarity, a variety of diseases is paralleled by alterations of 
systemic osmolarity. In addition, the intracellular volume constancy is continuously com-
promised by the generation of local and transient osmotic microgradients associated with 
uptake of nutrients, secretion, cytoskeletal remodeling, and transynaptic ionic gradients. 
Cell volume disturbances have particularly dramatic consequences in the brain. The 
limits to expansion imposed by the rigid skull give narrow margins for buffering of intra-
cranial volume changes. As expansion occurs, constraining of small vessels generates epi-
sodes of anoxia ischemia, infarct, excitotoxicity, and neuronal death. Under extreme 
conditions, caudal herniation of the brain parenchyma through the foramen magnum af-
fects brain stem nuclei, resulting in death by respiratory and cardiac arrest (1). 
Hyponatremia is the most common cause of hyposmotic swelling in brain cells. This 
condition results from an imbalance between intake and excretion of water and electrolytes 
derived from either an excess of water or a sodium (Na+) deficit. Water excess may derive 
from excessive oral intake as in psychotic polydipsia, or more commonly from impaired 
renal elimination as a consequence of inappropriate secretion of antidiuretic hormone, glu-
cocorticoid deficiency, hypothyroidism, use of thiazide diuretics, and renal or hepatic fail-
ure. A variety of diseases or conditions such as head trauma, brain tumor, and cerebro-
vascular accidents result in hyponatremia associated with the syndrome of inappropriate 
secretion of antidiuretic hormone (SIADH) or the cerebral salt-wasting syndrome (CSWS). 
Both syndromes have marked similarities with regard to clinical context and presentation, 
with euvolemia in SIADH and hypovolemia in CSWS the most clear contrasting variables. 
CSWS is characterized by excessive renal sodium loss (eventually in relation to a natriu-
retic factor) resulting in volume depletion and hyponatremia (2). Na+ loss also results from 
mineralocorticoid deficiency, nephrotic syndrome, osmotic diuresis, vomiting, or diarrhea. 
Hyponatremia may also be caused by rapid correction of uremia by excessive hemodialy-
sis and by infusion of hypotonic solutions in the perioperative period. Hyponatremia is a 
common state in the elderly and during pregnancy (3–5). Fatal hyponatremia-induced cer-
ebral edema has been recently associated with the use of the drug Ecstasy (6). 
 
Adaptive Response of Brain Cells to Hyposmotic Conditions: Studies in Vivo 
 
In the face of a decrease in external osmolarity, the brain does not exhibit the behavior 
predicted for a perfect osmometer. During chronic hyponatremia, only approximately 40% 
of the expected water gain occurs within the first hours; thereafter, total water content de-
creases progressively to nearly complete normalization (7). The first adaptive response is 
a compensatory displacement of liquid from the interstitial space to the cerebrospinal 
fluid; thereafter, the excess in cerebrospinal fluid enters the systemic circulation. The next 
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adaptive brain reaction is the extrusion of intracellular solutes, mainly the inorganic ions 
potassium (K+) and chloride (Cl–) and a number of small organic molecules, prominently 
amino acids with osmotically obligated water. Some loss of Na+ is also observed in whole 
brain studies, likely displaced from the extracellular space (8). Studies in animal models of 
chronic hyponatremia have shown the greatest loss of Na+ and Cl– during the first 3 h, 
while K+ loss is slower, achieving significance only after this first time period (8). From 
early studies on this subject, it was evident that the decrease in electrolytes was not suffi-
cient to compensate for the loss of water observed and that the involvement of other os-
motically active solutes needed to be considered. These molecules, initially referred to as 
idiogenic osmolytes, were further identified as organic molecules such as amino acids, polyal-
cohols, and methylamines, which were found to contribute significantly to the adaptive 
brain response to hyponatremia (8). A decrease in the concentration of myo-inositol, phos-
phocreatine/creatine, glycerophosphoryl choline and of the most abundant amino acids 
(glutamate, glutamine, taurine, and glycine) has been consistently observed in chronic hy-
ponatremia (9,10). The contribution of organic osmolytes and electrolytes to the total brain 
osmolarity change has been estimated as 23–29% and 62–70%, respectively (table 1). While 
decreases of electrolytes reverse with time, decreases of organic osmolytes, particularly 
taurine, are sustained as long as hyponatremic conditions persist (9). 
 
Table 1. Electrolytes and organic osmolyte content in rat brain during chronic hyponatremia 
Osmolyte (nmol/kg DBW)a Normonatremic 
Hyponatremic 
(nmol/kg DBW) Decrease 
Electrolytes    
   Sodium 279 250 29 
   Potassium 480 424 56 
   Chloride 152 118 34 
   All electrolytes 911 792 192 
Organic osmolytes    
   Glutamate 52.9 32.5 20.4 
   Glutamine 14.2 6.5 7.7 
   Taurine 13.8 2.1 11.7 
   GABA 1.7 0.9 0.8 
   Aspartate 2.2 1.7 0.5 
   N-acetylaspartate 7.5 5.9 1.6 
   Myo-inositol 16 5.3 10.7 
   Creatine 34.8 17.1 17.7 
   Phosphoethanolamine 1.2 0.8 0.4 
   GPCb 1.1 0.6 0.5 
   All organic osmolytes 145.4 73.4 72 
a. DBW: dry brain weight. Recalculated from (8,9). Data are from rats after 2–3 days of hyponatremia. 
b. GPC: glycerophosphorylcholine. 
 
Taken together, these studies show that immediate response to hyponatremia in brain 
is in charge of K+ and Cl– efflux, and that sustained adaptation is carried out by organic 
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osmolytes, particularly taurine. This has been confirmed in studies in vitro in astrocytes 
demonstrating how myo-inositol- and taurine swelling-activated efflux persists for several 
hours after the hyposmotic stimulus, in contrast to glutamate and K+, which remained un-
changed (11,12). These results highlight differences in handling the various osmolytes. 
Loss of K+ and Cl– is an emergency mechanism to counteract brain swelling rapidly, but it 
is potentially harmful on a long-term basis, in contrast to the relative innocuousness of 
most organic osmolytes. Taurine in particular may be a perfect osmolyte because it is met-
abolically inert and exhibits only weak synaptic interaction (13). 
Estimation of osmolyte change in all these studies does not discriminate among regional 
variations within the brain or possible differences in cell type. Studies in vitro, in tissue 
slices as well as in homogeneous cultured cells exposed to media of reduced osmolarity 
(by decreasing NaCl concentration), represent a suitable initial approach to clarify these 
questions and to obtain insight into the mechanisms of brain adaptation to hyponatremia. 
In-depth knowledge of these mechanisms is important to determine the development of 
symptoms in patients with hyponatremia and is critical for avoiding risks of inadequate 
correction procedures. 
 
Regulatory Volume Decrease: Cellular and Molecular Mechanisms 
 
Studies in cells such as neurons as well as glial cells in culture have contributed enor-
mously to our knowledge concerning the basic mechanisms of adaptive cell volume recov-
ery after hyposmotic swelling. Cells are, in general, highly permeable to water; therefore, 
any difference in osmolarity across the membrane results in net water movements in the 
direction necessary to reach osmotic equilibrium. In the face of a decrease in external os-
molarity, cells initially behave as nearly perfect osmometers and swell with a magnitude 
proportional to the osmolarity reduction. Immediately after, an active volume correction 
begins, based on the extrusion of intracellular solutes together with osmotically obligated 
water; this tends to reduce osmotic difference and normalize cell volume. This adaptive 
mechanism is known as regulatory volume decrease (RVD). The time necessary to fully 
activate RVD and regain cell volume is variable in the different cell types. In brain cells in 
vitro, RVD occurs rapidly, with a 70–80% recovery reached within a few minutes as a result 
of osmolyte activation (fig. 1A). 
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Figure 1. Regulatory volume decrease in cultured cerebellar granule neurons. A. Upon 
exposure to media of reduced osmolarity (50%), cerebellar granule neurons exhibit a 
rapid increase in cell volume followed by an active phase of volume regulation occurring 
despite the persistence of the hyposmotic medium. Volume recovery is approximately 
60% within 15 min. B. Volume recovery is accomplished by the efflux of inorganic and 
organic osmolytes () 3H-taurine (), 125I (as tracer for Cl–), and (●) 86Rb (as tracer for K+). 
Results are expressed as efflux rate constants, as described in the work of Sánchez-Olea et 
al. (14,26). 
 
RVD is a complex chain of events requiring a sensor to detect transient changes in cell 
volume, a signaling cascade to transduce information on volume change into activation of 
pathways for osmolyte extrusion, and a memory of the original cell volume that sets the 
timing for inactivation of the regulatory process. During the past years, the majority of 
efforts have been directed toward identifying and characterizing the osmolyte efflux path-
ways; thus, it is only recently that interest has been aroused in understanding osmotrans-
duction mechanisms. There is at present only scarce information concerning the nature of 
volume-sensing mechanisms. 
RVD has been studied in detail in astrocytes and neurons from primary cultures (14,15), 
in neuroblastoma (16), glioma cells lines (17), and in snail neurons (18). RVD has also been 
found in freshly isolated cells from hippocampus (19). The situation is unclear in more 
integrated preparations because in some of these preparations RVD has been undetectable 
(20); nevertheless, the results in vivo previously described clearly indicate the occurrence 
of compensatory mechanisms, although variations in ability to regulate volume may occur 
within brain regions. 
 
Pathways for Osmolyte Fluxes Activated during RVD 
The osmolytes responsible for RVD are essentially the same in most cell types including 
brain cells and are grouped into two broad categories: the most concentrated intracellular 
ions (K+ and Cl–) and small organic molecules, prominently amino acids, polyalcohols, sug-
ars, and methylamines. In most cells examined to date, osmolyte fluxes occur essentially 
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by diffusive pathways, i.e., K+ and Cl– efflux through separate channels with marginal par-
ticipation of electroneutral cotransporters, and organic osmolytes through leak pathways 
with no contribution of energy-dependent carriers (21). 
 
Osmosensitive Channels 
Volume-sensitive K+ and Cl– fluxes in most cell types occur through separate channels that 
may possess some interdependence but that clearly exhibited a different selectivity. Cl– 
channels activated by hyposmotic swelling are typically outward rectifiers with an inter-
mediate unitary conductance of 40–78 pS, inactivating at potentials of +60 mV and above. 
These channels have been characterized in numerous cell types (22,23). In brain cells, the 
volume-sensitive Cl– channel (VSCC) has been studied in astrocytes (24), C6 glioma cells 
(25), and cerebellar granule neurons (26). The VSCC has high selectivity of anions over 
cations but exhibits broad anion selectivity, being permeable to the majority of monovalent 
anions and even to large anions such as gluconate and methansulfonate. Activation of 
VSCC requires ATP but not its hydrolysis. Typical Cl– channel blockers such as DIDS, SITS, 
9-AC, and DPC inhibit VSCC with different potencies according to cell type. Other agents 
with inhibitory effects on the VSCC include NPPB, DDF, niflumic acid, and flufenamic 
acid (23,24). Notably, arachidonic acid and other polyunsaturated fatty acids are potent 
VSCC blockers (27,28). For details on the basic properties of VSCC, readers are referred to 
recent reviews on this topic (22,23). 
The molecular species of VSCC are as yet unidentified. Approximately eight members 
of a family of voltage-gated Cl– channels have been cloned and characterized. Some are 
activated by swelling (29), but none unequivocally corresponds to VSCC. Some evidence 
appears to support the ClC3 channel gene as encoding the channel protein responsible for 
the volume-sensitive Cl– current (30), but recent evidence argues against this channel being 
indeed the VSCC (31). Some molecules with Cl– permeability properties, namely Icln and 
the P-glycoprotein, are suggested to play a role in osmosensitive Cl transport either as a 
Cl– pathway properly, a possibility recently questioned, or as regulating elements of the 
functional Cl– channels (review in Reference 30). Not unlikely but at present undefined is 
the question of whether different types of VSCC and other anion-permeating molecules 
coincide in the same cell. An interesting avenue for future research may be the identifica-
tion of the factors and situations that determine the functioning of one or another of these 
different osmosensitive channels. 
In contrast to the broad similarities found for VSCC in different types of cells, swelling 
activates at least two different types of K+ channels. In some—mainly epithelial—cells, 
volume-sensitive K+ channels (VSKC) are calcium (Ca2+)-dependent, large-conductance 
(100–200 pS) channels. In other cell types, VSCK channels are small channels with conduct-
ances of 20–30 pS, the majority Ca2+-independent (review in Reference 32). While the first 
group of channels has been clearly identified as high conductance K+ channels, the identity 
of the second group is still unclear. Some types of voltage-gated K+ channels appear to 
permeate K+ efflux during RVD in lymphocytes, and Kv channels are activated by hy-
posmolarity in hippocampal pyramidal neurons, although not all Kv subtypes are respon-
sive (32). 
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Volume-Sensitive Pathways for Organic Osmolytes 
A number of organic osmolytes are released during hyposmotic swelling, but the details 
of their efflux pathways are known for only a few. The best-characterized organic osmo-
lytes are those for taurine and myo-inositol (33–35); additionally, there is some information 
on N-acetyl aspartate and ascorbate (36,37). In general, these are bidirectional leak path-
ways with net solute movement depending on concentration gradient direction. Remark-
ably, organic osmolyte pathways commonly exhibit a pharmacologic profile similar to that 
of the VSCC, suggestive of a common pathway with Cl– or of a close connection between 
the two pathways (21,35). Other amino acids also responsive to swelling are glycine, 
GABA, glutamate, and aspartate, which contribute to correction of osmotic disturbance 
(38). However, this may create additional risks of excitability imbalance, due to their prom-
inent role as synaptic transmitters, to be discussed later. There is recent evidence on 
hyposmolarity-induced glutamate release insensitive to Cl– channel blockers, at clear var-
iance with other organic osmolytes (39). This is suggestive of either different pathways or 
different stimuli and mechanisms for release of this particular amino acid. 
 
Volume Sensor and Osmotransductive Signaling 
How cells sense volume changes is the initial and critical step in the chain of reactions 
activated for volume correction, yet this has remained elusive to date. Among possible 
mechanisms considered to play this role are membrane receptors such as integrins or re-
ceptors with intrinsic tyrosine kinase activity, cytoskeleton rearrangements, dilution of cy-
tosolic macromolecules, decrease in intracellular ionic strength, stretch-induced activation 
of adhesion molecules, activation of phospholipases, or changes in the concentration of 
signaling molecules such as Ca2+ or magnesium (Mg2+) (fig. 2). Although to date none of 
these possesses sufficient supporting experimental evidence, this is at present a very active 
field of research (40). The question of volume sensing is also closely related to mechanisms 
of osmolyte flux inactivation. At present, this is an essentially unexplored aspect of RVD. 
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Figure 2. Hypothetical scheme of the elements of volume sensing, osmotransduction, and 
activation of osmolyte pathways. The volume sensor system includes membrane and sub-
membrane elements such as integrins, membrane receptors with intrinsic tyrosine kinase 
activity (TKR), annexins, and cortical actin cytoskeleton remodeling. Osmotransduction 
signaling includes Ca2+ and a number of protein tyrosine kinases, including focal adhesion 
kinase (FAK), SYK, src-related kinases (srck), the tyrosine-kinase-activated kinase phos-
phoinositide-3 kinase (PI3K), and protein kinase C (PKC). The small GTPase Rho and its 
kinase RhoK may also act as osmosignaling elements. Not all enzymes appear involved 
in the same cell type. 
 
Calcium and protein kinases are among the most likely candidates to act as osmotrans-
ductory elements. One of the most constant features of hyposmotic swelling is an increase 
in cystolic Ca2+ (32) (fig. 2). Despite this, the main corrective osmolyte efflux pathways and 
consequently RVD are Ca2+-independent in a large variety of cell types. This is the case for 
brain cells, in which VSCC, VSKC, and organic efflux pathways are largely Ca2+-independent 
(32). The more commonly accepted interpretation of these results is that cytosolic Ca2+ in-
crease is an epiphenomenon resulting from activation by swelling of Ca2+ influx pathways 
and/or of release mechanisms from intracellular stores (41), but that this increase is not 
part of the osmosignaling cascades. In cells such as epithelial cells, the magnitude of hy-
posmolarity-evoked cytosolic Ca2+ elevation is sufficient to activate Ca2+-dependent large 
conductance K+ channels, which once activated, predominantly contribute to RVD. As a 
consequence, RVD is Ca2+-dependent in these cells (32). 
Protein kinases of different types modulate some osmolyte pathways. In contrast to the 
constancy of the cytosolic Ca2+ elevation, the effect of protein kinases appears to be cell-
specific. Protein kinase C (PKC) appears involved in the function of the VSCC but with 
different effects (activation or inhibition) according to cell type (22). Protein kinase A does 
not influence RVD in most cells but may be involved in the modulatory action of hormones 
and other factors on cell volume regulation. Protein tyrosine kinases (PTK) have recently 
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received special attention as elements of the osmotransduction cascades as a result of the 
potent effect of blockers of PTK reducing the osmosensitive efflux of Cl– and taurine 
(42,43). This effect has been reported in cultured astrocytes and neurons and in more inte-
grated preparations such as the supraoptic nucleus and hippocampal slices (34,39). In vivo, 
PTK appear related to swelling-evoked amino acid release in heart Langendorff prepara-
tions (44). Furthermore, in cultured cells inhibition of tyrosine phosphatases, which pro-
long the protein phosphorylation reaction, increases osmolyte fluxes (42) (fig. 2). A 
modulatory role of PTK on volume-sensitive K+ channels has not been reported but Ca2+ 
and PKC are involved in VSKC in some cell types, as previously mentioned (fig. 2). 
The site within the complex signaling network modulated by PTK has not been identi-
fied. A possible target is the phosphoinositide kinase PI3K, a tyrosine-kinase-activated ki-
nase, because inhibition of this enzyme has a marked influence in reducing the volume-
corrective fluxes of Cl– and taurine (42,43). PI3K is a key element in signaling cascades with 
links to tyrosine-kinase membrane receptors and the integrin-FAK pathway. PI3K also re-
lates to small GTP-ases of the Rho family that in turn modulate the dynamics of the cyto-
skeleton (45) (fig. 2). 
A role for phospholipases in osmotransduction, in particular the cPLA2 form, is sug-
gested by reports in neuroblastoma and in Ehrlich ascites cells, showing a strong correla-
tion between arachidonic acid release and volume-sensitive taurine efflux, which are 
blunted by blockers of this specific enzyme (46). 
 
Isovolumetric Regulation 
The experimental model of abrupt and large reduction in external osmolarity has contrib-
uted importantly to our knowledge concerning the mechanisms by which cells face os-
motic challenges. However, this model does not closely reproduce the conditions in vivo. 
Even in acute hyponatremia, changes in external osmolarity never exceed –16% and onset 
of hyposmolarity appears gradually. A better paradigm for approaching these conditions 
was developed by Lohr and Grantham (47) in renal tubule cells exposed to small and grad-
ual changes in osmolarity. Under these conditions, cells do not swell even if external os-
molarity is drastically decreased. This constancy in cell volume is not due to swelling being 
restricted, but is rather due to rapid and efficient correction of the continuous change in 
water content. This volume adjustment, similar to models of abrupt hyposmotic shock, 
appears to be accomplished by active extrusion of intracellular osmolytes (48). Molecules 
involved and mechanisms in operation are not known in detail, as studies on isovolumetric 
regulation (IVR) are still scarce. Occurrence of IVR has been found in only two types of 
renal cells (47,49), in hippocampal slices (50) (fig. 3), and with lower efficiency in C6 glioma 
cells (51) and in cardiomyocytes (52). In A6 cells and in myocytes, IVR stimulates K+ re-
lease, but only at delayed phase of IVR, with an efflux threshold at –30% hyposmotic ex-
ternal osmolarity. In contrast, amino acids, particularly taurine, appear involved at earlier 
phases of volume regulation, showing efflux thresholds at approximately –10 to 12% hy-
posmolarity (50) (fig. 3). There is no information on osmotransduction factors or signaling 
messengers involved in this model of volume regulation, and possible similarities or dis-
similarities of this mechanism of volume control in different cell types have not been ex-
plored to date. This is an interesting avenue of research because as previously mentioned, 
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this experimental model approaches physiologic and pathologic situations generating 
changes in cell volume in brain. 
 
 
 
Figure 3. Isovolumetric regulation in hippocampal slices. A. Slice water content remains 
unchanged when slices are exposed to small and gradual changes in osmolarity (1.8 
mosm/min). B. Constancy in cell volume is an active process accomplished by the efflux 
of osmolytes, as illustrated for taurine efflux. Details of experiments are described accord-
ing to Franco et al. (49). 
 
Hyponatremia and Hyperexcitability 
 
A serious clinical consequence of acute and severe hyponatremia is the generation of epi-
leptiform activity and increased susceptibility to seizures (53). In studies in hippocampal 
slices, osmolarity reduction causes an increase in amplitude of evoked field potentials and 
of excitatory postsynaptic potentials, which is inversely related to osmolarity (54). Hy-
posmolarity does not affect cell properties such as resting membrane potential, cell input 
resistance, and action potential threshold and duration (55). The manner in which osmo-
larity alters synaptic transmission is not fully understood. It may result from either hyper-
function of excitatory synapses and/or from nonsynaptic mechanisms derived from 
reductions in the size of the extracellular space. The increase in excitatory synaptic activity 
may be the consequence of the well-documented, swelling-activated glutamate release 
(39,55). On the other hand, narrowing of the extracellular space due to cell swelling may 
also be a source of hyperexcitability, either by enhancing ephaptic interactions and/or be-
cause increase of extracellular K+ concentration and reduced diffusion of neurotransmitters 
prolong the synaptic function (53,56). These possibilities, which do not exclude each other, 
may all contribute to generate hyposmotic-associated hyperexcitability. In support of this 
interpretation, the Cl– channel blocker furosemide prevents extracellular space reduction 
and blocks epileptiform activity in a variety of in vitro models (57). Furosemide prevents 
the kainic acid-induced, synchronized burst discharges in hippocampal slices (57). 
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Differences in Brain Cell Swelling in Hyponatremia 
 
Cultured brain cells exposed to hyposmolarity reductions exhibit an immediate and gen-
eral increase in cell swelling. However, this homogeneity has not been observed in more 
integrated preparations, in which the response of individual neurons to lowering osmo-
larity varies greatly. In pyramidal cells freshly isolated from CA1 region of the hippocam-
pus, at least three different populations of cells could be identified according to their 
response to decreasing osmolarity. One group of cells swells immediately, while other 
groups exhibit a delayed response or are resistant to swelling (19). Differences are also 
observed between hippocampal regions in which CA1 and the dentate gyrus swell more 
than CA3 (58). Within the same region, as in CA1, the stratum radiatum and the stratum 
oriens containing the apical and basal dendrites, respectively, are notably more responsive 
to hyposmotic swelling than the stratum pyramidale, formed by the cell somata (58). The 
reason for these differences is unclear to date. Lack of swelling in some cells or regions 
may result from (i) an intrinsic mechanism preventing water entry such as reduced expres-
sion of aquaporins, (ii) activation of highly efficient processes of volume adjustment, or 
(iii) temporary redistribution of osmolytes to nearby cell compartments. In this respect, an 
elegant in vivo study by Nagelhus and co-workers (59) in cerebellum of water-loaded rats 
shows an immediate redistribution of taurine-cell content in Purkinje cells to nearby glial 
elements in response to the hyposmotic condition. As a result, astrocytes swell while neu-
rons are spared (fig. 4). 
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Figure 4. Redistribution of taurine-like immunoreactivity in rat cerebellar cortex follow-
ing water loading. Details of the experiment are as in Reference 58. Photomicrographs of 
pairs of neighboring semi-thin sections treated with taurine antiserum are as described in 
Reference 58. Animals were treated with isotonic saline (A) or water (B) 4 h prior to kill-
ing, or with water followed by hypertonic saline (C). The figure shows the highly concen-
trated taurine in Purkinje cells (large arrows), which upon water load is transferred to the 
adjacent glial elements (arrows). The original distribution is restored after hyposmolarity 
correction. Double arrowheads represent different types of cells labeled with taurine. This 
is part of figure 2 from the work by Nagelhus et al. (58), reproduced with permission. 
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Risks of Rapid Correction of Hyponatremia 
 
Acute, severe hyponatremia (Na+ serum concentration <115 mM) produces clear symp-
toms of neurologic damage due to brain edema, with the consequent increase in intracra-
nial pressure. The commonly used procedure to correct hyponatremia is administration of 
hypertonic saline solutions. Saline/acetate solutions have also proved highly efficient to 
correct mild hyponatremia (60). In cases of SIADH, fluid restriction is usually the first line 
of treatment. It is important to mention in this respect that a clear distinction should be 
made between a diagnosis of SIADH and of CSWS, which as mentioned previously may 
have similar symptoms. While fluid restriction is appropriate to correct hyponatremia as-
sociated with SIADH, it is detrimental to patients with CSWS and can even be lethal (2,61). 
An increase in plasma Na+ concentration of approximately 10–15 mmol/L is normally suf-
ficient to prevent permanent brain damage in severe, acute hyponatremia. It is currently 
accepted that the rate of correction of acute hyponatremia should be no more than 0.5 
mmol/L/h and should be interrupted when serum Na+ levels have increased to 125–130 
mmol/L (62). These precautions are necessary because overly excessive and rapid correc-
tive procedures may result in brain injury, likely due to the adaptive mechanisms devel-
oped to counteract hyponatremia described in this review. As a consequence of these 
adjustments, solute intracellular pools change their concentration to attain an osmotic bal-
ance with the external modified condition, i.e., the osmolarity of the cytosol is in equilib-
rium with an external hyposmotic environment. When the increase in plasma tonicity that 
accompanies correction of chronic hyponatremia restores the normal isosmotic condition, 
this condition is now sensed as hyperosmotic by brain cells, which consequently dehydrate 
until new adaptive mechanisms are activated. The main risk of this situation is a neurologic 
sequel of demyelinating lesions in the brain, a pathology known as osmotic demyelination 
syndrome (8). This pathologic entity is characterized by a symmetric focus prominently in 
the basis pontis, but extrapontine demyelinating lesions have also been found in the basal 
ganglia, internal capsule, lateral geniculate body, and cortex (63). The salient clinical fea-
tures of the syndrome include motor abnormalities progressing to flaccid quadriplegia, 
occasional respiratory paralysis, mental state disturbances, lethargy, and coma. Why de-
myelination develops is not well understood. Recent studies have focused on a disruption 
of the brain blood barrier as the gating factor of the degenerative process (64,65). The cur-
rent hypothesis is that disruption of the tight junctions of the blood brain barrier as a con-
sequence of brain dehydration might expose oligodendrocytes to substances normally 
excluded from the brain, such as complement, which could be the precipitous factor of 
demyelination. Situations predisposing to the development of the demyelination syn-
drome associate with preexisting conditions such as alcoholism and malnutrition (8). Par-
ticular care should be taken in correcting hyponatremia in patients with an associated 
clinical condition of hypoxia. Studies in animals as well as in humans (66–68) have shown 
that hypoxia combined with hyponatremia produces a major increase in brain edema, in-
jury, and mortality. This is possibly a consequence of inefficiency of the compensatory 
mechanisms of cell volume regulation due to intracellular Na+ increase and subsequent Cl– 
influx occurring in the hypoxic condition as a result of the energetic failure (69). 
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Conclusions 
 
Knowledge concerning the cellular and molecular mechanisms subserving brain adapta-
tion to hyponatremia has notably progressed in the last decade. All of this information has 
contributed to understanding the risk of the pathologic consequences of an inappropriate 
correction of the hyponatremic patient and to guide the clinicians toward a rational, opti-
mal therapeutic approach. 
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